Antitubercular Drugs for Pulmonary Tuberculosis
Aug 24, 2022
Source: Cainiu Health
Dr. Jiang Weimin
Introduction
The medications used to treat pulmonary tuberculosis include isoniazid and ethambutol. Tuberculosis treatment primarily involves bactericidal and bacteriostatic effects: bactericidal action directly kills Mycobacterium tuberculosis, whereas bacteriostatic action slows the replication of the bacteria. Commonly used bactericidal drugs for pulmonary tuberculosis include isoniazid, rifampin, pyrazinamide, and streptomycin; ethambutol is classified as a bacteriostatic antimicrobial agent.
Tuberculosis (TB) is a common pulmonary disease. Its clinical symptoms include low-grade fever, fatigue, and coughing. Patients with mild disease can achieve full recovery following appropriate treatment; however, severe cases may become life-threatening. Therefore, tuberculosis warrants serious attention. What are the medications used to treat pulmonary tuberculosis?
Medications for Pulmonary Tuberculosis
The primary anti-tuberculosis drugs include isoniazid and ethambutol. TB treatment mainly involves bactericidal and bacteriostatic mechanisms: bactericidal agents directly kill Mycobacterium tuberculosis, whereas bacteriostatic agents slow bacterial replication. Commonly used bactericidal drugs for pulmonary TB include isoniazid, rifampin, pyrazinamide, and streptomycin; ethambutol is classified as a bacteriostatic antimicrobial agent. Typically, TB treatment employs combination therapy—using two or more drugs simultaneously. With standard 6-month treatment regimens, the majority of patients achieve cure.
First, anti-tuberculosis medications may cause hepatotoxicity; therefore, liver function tests must be performed regularly during treatment, and hepatoprotective agents may be prescribed when necessary. During rifampin therapy, bodily secretions—including sweat, urine, and tears—may turn reddish-orange; this is a well-documented, benign side effect and does not require undue concern. Patients must strictly adhere to their physician’s instructions and must not discontinue medication without medical guidance. Premature or inappropriate cessation of treatment may result in incomplete eradication of the pathogen and development of drug resistance. Cough and sputum production are common symptoms of pulmonary TB. In early-stage disease, cough is typically mild and may present as a dry cough or with only small amounts of viscous sputum. As the disease progresses, cough intensity often increases, accompanied by greater sputum volume or purulent sputum.
Patients are advised to undergo drug susceptibility testing using cultured M. tuberculosis isolates to guide optimal therapeutic decision-making. We hope this information proves helpful.
